Award Health

Edoxaban Review Service W91039

Buyers: Betsi Cadwaladr University Health Board

DEADLINE: Awarded

This tender has been awarded.

REGION: Wales

Main delivery area

Description excerpt

The service is to review those prescribed edoxaban in primary care with a view to changing them to a more cost effective alternative.... Read more

VALUE

£4K

Estimated value

TYPE

Contract

Services

SME FIT

-----

No info

DURATION (est.)

-----

Not specified

Related Terms

Quick Actions

As a subscriber you can save this tender or set notifications for updates.

Geochart for 2 buyers and 1 suppliers

1 Supplier

Description

The service is to review those prescribed edoxaban in primary care with a view to changing them to a more cost effective alternative.

Total Quantity or Scope

Edoxaban Review Service is a service that requires a clinical review of all patients prescribed edoxaban for atrial fibrillation registered with GPs in BCUHB to assess if they are suitable for a more cost effective alternative and then change those that are. Part 1 - Edoxaban Patient Review Clinical review of the records of patients prescribed edoxaban. Anyone not deemed suitable for the switch must be evidenced in the records, consider using the phrase Edoxaban switch not clinically appropriate (no code) or, Edoxaban contraindicated (SNOMED CT:2949391000000118) or, Adverse reaction to edoxaban (SNOMED CT:1957181000006103). Those deemed suitable for a switch proceed to a consultation with the patient or their representative. Consultations to switch edoxaban to generic apixaban or generic rivaroxaban can be done via telephone, virtually or face-to-face. This must be documented in the notes, consider using the phrase Edoxaban switch clinically appropriate (no code) or, Edoxaban declined (SNOMED CT:1443911000000106) Part 2 - Edoxaban Patient Review that results in a switch to generic apixaban or generic rivaroxaban If clinically appropriate and the patient agrees to the switch to either generic rivaroxaban or generic apixaban; prescribe as indicated. This is a new service and will run from 1st August 2026 until 31st January 2027. This is a Provider Selection Regime Wales (PSR Wales) intention to award notice. The awarding of this contract is subject to the Health Services (Provider Selection Regime) (Wales) Regulations 2025. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015/Procurement Act 2023 do not apply to this award.

Award Detail

1 Deeside Medical Centre (Shotton)
  • Reference: bcu-msp02-edoxaban-w91039
  • Num offers: 1
  • Value: £3,780
  • Contractor is an SME.

Award Criteria

most suitable provider process with regard to the key criteria 100.0
most suitable provider process with regard to the key criteria _

CPV Codes

  • 85121100 - General-practitioner services

Indicators

  • Award on basis of price and quality.

Other Information

This is a Provider Selection Regime Wales (PSR Wales) intention to award notice. The awarding of this contract is subject to the Health Services (Provider Selection Regime) (Wales) Regulations 2025. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015/Procurement Act 2023 do not apply to this award. The publication of this notice marks the start of the standstill period. Representations by providers must be made to decision makers by 11.59pm 6th August 2026. This contract has not yet formally been awarded; this notice serves as an intention to award under the PSR Wales. The decision makers were the Associate Director Primary Care, Medical Director Primary Care, Head of Pharmacy Primary Care, Primary Care Contracts Manager and Clinical Governance Managers. There are no noted conflict of interests. As part of the review all basic and key criteria were included with a pass/ fail weighting for all criteria and an award being made when all criteria were met. The Health Board determined that, due to the low-risk and highly specified nature of the service, providers would be assessed against mandatory requirements aligned to the PSR key criteria. Providers demonstrating appropriate clinical governance arrangements, capacity to deliver the reviews within the service period, compliance with the DOAC LSS and acceptance of the service specification were awarded contracts. Providers failing to satisfy one or more mandatory requirements were not awarded. This provider met all criteria. (WA Ref:168375)

Reference

  • FTS 070773-2026

Domains